EnBiotix
Boston, US · Delaware corporation
Find your way into EnBiotix
Founders & leadership
JD
Jeffrey D. WagerFounder
DH
Daniel HartmanNamed on SEC filing
RG
Roberto GuttmannNamed on SEC filing
DA
Dennis AusielloNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$6.6M disclosed across 2 of 3 rounds · 2019–2021
▶$3.5MraisedApr 2022 · 11 investors · PharmaceuticalsRule 506(b)
▶$3.5MraisedApr 2022 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Dennis AuiselloDirector
- Roberto GuttmannDirector
- Daniel HartmanDirector
- Jeffrey D. WagerExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $3.5M
- Proceeds to insiders
- $180K
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.1MraisedSep 2019 · 3 investors · PharmaceuticalsRule 506(b)
▶$3.1MraisedSep 2019 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Daniel HartmanDirector
- Roberto GuttmannDirector
- Dennis AusielloDirector
- Jeffrey D. WagerExecutive Officer, Director
- Offering amount
- $26M
- Amount sold
- $3.1M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $263.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded EnBiotix?
- EnBiotix was founded by Jeffrey D. Wager.
- How much funding has EnBiotix raised?
- EnBiotix has disclosed $6.6M raised across 2 of its 3 known rounds.
- Where is EnBiotix headquartered?
- EnBiotix is headquartered in Boston, US.